CCTN - MALE CONTRACEPTIVE - DMAU 28 DAY STUDY
$356,318N01FY2019HDNIH
University Of Washington, Seattle WA
Investigators
Abstract
Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man as clinical trial for contraception.
View original record on NIH RePORTER →